Compliances-Certificate under Reg.74(5) of SEBI (DP) Regulations,2018
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bacil Pharma has submitted to BSE a quarterly compliance certificate from its Registrar and Transfer Agent, Bigshare Services Pvt. Ltd., under SEBI's Depository Regulations. The certificate confirms that all securities received for dematerialisation during the quarter ended 31 December 2025 were properly processed, listed on the stock exchange, and that physical share certificates were mutilated and cancelled after verification. It also confirms that the depository's name was substituted as the registered owner in the company's records within the SEBI-mandated 15-day window. No new shares were issued and no corporate action is involved in this filing.
This is a routine, procedural regulatory filing with no material impact on shareholders, business operations, or the stock price. It simply evidences that the company's RTA handled dematerialisation requests in compliance with SEBI rules.